SCHEMBL5741124

SCHEMBL5741124

Cc1noc2nc(CCCNC(=O)CC#N)n(Cc3ccccc3)c(=O)c12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
KIF11 P52732 1/20 0.42
ENPP2 Q13822 1/20 0.41
PDE4A P27815 3/20 0.40
PDE4B Q07343 3/20 0.40
PDE4C Q08493 3/20 0.40
PDE4D Q08499 3/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 2/20 0.39
MCL1 Q07820 1/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
PPARG P37231 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208538 0.81 PDE4A (0.51) SMN1; SMN2KIF11ENPP2PDE4APDE4B
SCHEMBL5246052 0.80 TLR7 (0.43) SMN1; SMN2KIF11ENPP2PDE4APDE4B
SCHEMBL5246246 0.79 PDE4A (0.49) SMN1; SMN2KIF11PDE4APDE4BPDE4C
SCHEMBL5741127 0.79 KIF11 (0.48) SMN1; SMN2KIF11PDE4APDE4BPDE4C
SCHEMBL3871568 0.79 SMN1; SMN2 (0.53) SMN1; SMN2KIF11PDE4APDE4BPDE4C
SCHEMBL5899045 0.77 KIF11 (0.51) SMN1; SMN2KIF11POLBMEN1GAA
SCHEMBL5739696 0.77 KIF11 (0.55) SMN1; SMN2KIF11PDE4APDE4BPDE4C
SCHEMBL4042840 0.74 KIF11 (0.53) SMN1; SMN2KIF11TSHRMEN1GAA
SCHEMBL3905973 0.73 KIF11 (0.51) KIF11
SCHEMBL3901729 0.73 SMN1; SMN2 (0.48) SMN1; SMN2KIF11PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628981-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004106492-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-09 WO disclosed